Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Trump administration awards contract to make COVID-19 drugs in U.S.

EconomyMay 19, 2020 11:05AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. U.S. President Trump hosts coronavirus response event with restaurant executives and industry leaders at the White House in Washington

By Michael Erman and Ankur Banerjee

(Reuters) - U.S. President Donald Trump's administration awarded a contract worth up to $812 million for a new U.S. company to manufacture drugs and drug ingredients to fight COVID-19 on American soil, aiming to end dependence on other countries.

The administration has been looking to build up the ability to produce drugs and their raw materials in the United States after the global pandemic exposed the industry's dependence on China and India for its supply chain.

"For far too long, we've relied on foreign manufacturing and supply chains for our most important medicines and active pharmaceutical ingredients while placing America's health, safety, and national security at grave risk," Peter Navarro, director of the White House Office of Trade and Manufacturing Policy, said in a statement.

The U.S Department of Health and Human Services said on Tuesday that it had awarded a 4-year, $354 million contract to privately-held Phlow Corp to make COVID-19 drugs, other essential drugs and their ingredients. The contract can be extended for up to $812 million over 10 years.

Phlow, which was incorporated in January, said the contract will help it contribute to a national stockpile of active pharmaceutical ingredients for essential medicines.

It said it had already started making pharmaceutical ingredients and finished dosage forms for over a dozen essential medicines to treat hospitalized patients with COVID-19-related illnesses. It has delivered over 1.6 million doses of five essential generic medicines used to treat COVID-19 patients to the U.S. Strategic National Stockpile. 

Many of these medicines are in shortage and have previously been imported. India and China account for a vast majority of active pharmaceutical ingredients used to make drugs in the United States.

Phlow has partnered with other groups including Civica Rx, Ampac Fine Chemicals and the Medicines for All Institute to manufacture the medicines.

All pharmaceutical products by Phlow will be made in the United States, according to the company's website. The company said it is working to build advanced manufacturing capability in Virginia, as well as sterile injectables manufacturing facilities.

Trump administration awards contract to make COVID-19 drugs in U.S.
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (2)
scola phil
scola phil May 19, 2020 12:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
28 days laters
Harsha Rao
Harsha Rao May 19, 2020 9:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Entire article goes on about essential medicines without naming one single generic medicine. Where did 350 million dollars go?. For what?. To manufacture useless Hydroxychloroquine?. Hum suspicious as to what happened to the money.
john lim
john lim May 19, 2020 9:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Corruption.
Me comment
Me comment May 19, 2020 9:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It is payback by Trump to the owners who were big donors to his 2016 election and his re-election campaign.
gugogi GR
gugogi GR May 19, 2020 9:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Don't think so
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email